Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Karen Kadish"'
Autor:
Sandhya Upasani, Jacqueline C. Barrientos, Nilanjan Ghosh, Anthony R. Mato, Jeff P. Sharman, Israel Arango-Hisijara, Meghan Gutierrez, Qing Huang, Karen Kadish, Danielle M. Brander, Jennifer Han, Reethi Iyengar
Publikováno v:
Blood. 136:42-43
Background: Treatment options, together with guidelines, for pts with CLL have evolved and expanded with the introduction of novel agents. The informCLLTM registry is the largest US-based prospective, observational registry of pts who received treatm
Autor:
Brian Tomlinson, Murali Sundaram, Meghan Gutierrez, Jennifer Han, David Ipe, Jacqueline C. Barrientos, Carlos I. Amaya-Chanaga, Anthony R. Mato, Nilanjan Ghosh, John M. Pagel, Sandhya Upasani, Jeff P. Sharman, Karen Kadish, Reethi Iyengar, Nick Giafis, Danielle M. Brander
Publikováno v:
Clinical lymphoma, myeloma & leukemia
informCLL is the first United States-based registry of patients with chronic lymphocytic leukemia that initiated enrollment after approval of novel targeted agents. Prognostic/predictive testing rates and chronic lymphocytic leukemia treatment select
Autor:
Sandhya Upasani, Carlos I. Amaya-Chanaga, Nilanjan Ghosh, Murali Sundaram, J. Han, Karen Kadish, Reethi Iyengar
Publikováno v:
Value in Health. 23:S89
Autor:
Murali Sundaram, Carlos I. Amaya-Chanaga, R. Iyengar, M. Gutierrez, Sandhya Upasani, Anthony R. Mato, N. Ghosh, B. Tomlinson, L. Ferrante, Karen Kadish, Jeffrey P. Sharman, D. Ipe, John M. Pagel, D. Brander, Jaqueline C. Barrientos, N. Giafis
Publikováno v:
HemaSphere. 3:143-144
Autor:
Nilanjan Ghosh, John M. Pagel, Sandhya Upasani, Meghan Gutierrez, Jacqueline C. Barrientos, Lucille Ferrante, David Ipe, Anthony R. Mato, Danielle M. Brander, Nick Giafis, Karen Kadish, Carlos I. Amaya-Chanaga, Brian Tomlinson, Jeff P. Sharman, Murali Sundaram, Reethi Iyengar
Publikováno v:
Blood. 132:4425-4425
Background : Prior to the approvals of ibrutinib (ibr), idelalisib, and venetoclax, data from the Connect CLL registry showed that across 199 US centers only 65% of patients (pts) had FISH testing and 6% had IGHV testing performed prior to the first
Autor:
David Ipe, Anthony R. Mato, Lucille Ferrante, Jeff P. Sharman, Murali Sundaram, Brian Tomlinson, Nick Giafis, Reethi Iyengar, Karen Kadish, Carlos I. Amaya-Chanaga, Sandhya Upasani, Danielle M. Brander, Meghan Gutierrez, Jacqueline C. Barrientos, Nilanjan Ghosh, John M. Pagel
Publikováno v:
Blood. 132:1872-1872
Background : Chronic lymphocytic leukemia (CLL) treatment (tx) has changed dramatically with the emergence of novel targeted therapies, and real-world data from observational studies continue to improve our understanding of tx patterns/outcomes. Begi